SEC Form 10-Q filed by INNOVATE Corp.

PHOENIX, Jan. 30, 2026 (GLOBE NEWSWIRE) -- DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE:VATE), announced today that it will pay a cash dividend of approximately $5 million, or $1.30 per share, on February 24, 2026 to DBMG's stockholders of record at the close of business on February 9, 2026. About DBM Global Inc. DBMG is focused on delivering world class, sustainable value to its clients through a highly collaborative portfolio of companies which provide better designs, more efficient construction, and superior asset management solutions. The Company offers integrated steel cons

- Infrastructure: DBM Global delivers robust revenue growth, reinforcing market leadership -- Life Sciences: MediBeacon received regulatory approval to sell the Transdermal GFR System in China -- Spectrum: New network launches underway; Fourth quarter advertising sales showing early signs of recovery - NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the third quarter.  Financial Summary (in millions, except per share amounts)Three Months Ended September 30, Nine Months Ended September 30,  2025   2024  Increase / (Decrease)  2025   2024  Increase / (Decrease)Revenue$347.1  $242.2  43.3% $86

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the third quarter 2025 on Wednesday, November 12, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "I

4 - INNOVATE Corp. (0001006837) (Issuer)

4 - INNOVATE Corp. (0001006837) (Issuer)

4 - INNOVATE Corp. (0001006837) (Issuer)

4/A - INNOVATE Corp. (0001006837) (Issuer)

4 - INNOVATE Corp. (0001006837) (Issuer)

4 - INNOVATE Corp. (0001006837) (Issuer)

8-K - INNOVATE Corp. (0001006837) (Filer)

10-Q - INNOVATE Corp. (0001006837) (Filer)

8-K - INNOVATE Corp. (0001006837) (Filer)

MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this role, Dr. Miller will be focused on driving a range of clinical and strategic initiatives. Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and per

Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/

NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. "Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she will help guide us in our mission to drive shareholder value across our Infrastructure, Life Sciences and Spectrum operating segments," said Avie Glazer, Chairman of INNOVATE. "Amy's leadership and strategy consulting experience advising Fortune 500 companies will be a valuable addition to our Board," said Wayne Barr, Jr., Chief Executive Officer of INNOVATE